RAYONIER ADVANCED MATERIALS (RYAM) Fundamental Analysis & Valuation

NYSE:RYAM • US75508B1044

Current stock price

9.62 USD
-0.13 (-1.33%)
At close:
9.62 USD
0 (0%)
After Hours:

This RYAM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. RYAM Profitability Analysis

1.1 Basic Checks

  • In the past year RYAM has reported negative net income.
  • RYAM had a positive operating cash flow in the past year.
  • In the past 5 years RYAM reported 4 times negative net income.
  • Each year in the past 5 years RYAM had a positive operating cash flow.
RYAM Yearly Net Income VS EBIT VS OCF VS FCFRYAM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M

1.2 Ratios

  • RYAM has a Return On Assets of -23.92%. This is amonst the worse of the industry: RYAM underperforms 89.02% of its industry peers.
  • RYAM has a worse Return On Equity (-132.89%) than 87.80% of its industry peers.
  • RYAM has a Return On Invested Capital of 0.57%. This is in the lower half of the industry: RYAM underperforms 70.73% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for RYAM is below the industry average of 6.49%.
Industry RankSector Rank
ROA -23.92%
ROE -132.89%
ROIC 0.57%
ROA(3y)-10.14%
ROA(5y)-5.67%
ROE(3y)-50.65%
ROE(5y)-29.12%
ROIC(3y)1.56%
ROIC(5y)N/A
RYAM Yearly ROA, ROE, ROICRYAM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100

1.3 Margins

  • RYAM has a worse Operating Margin (0.68%) than 73.17% of its industry peers.
  • RYAM's Operating Margin has declined in the last couple of years.
  • RYAM's Gross Margin of 8.10% is on the low side compared to the rest of the industry. RYAM is outperformed by 85.37% of its industry peers.
  • RYAM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 0.68%
PM (TTM) N/A
GM 8.1%
OM growth 3Y-26.22%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.16%
GM growth 5Y11.42%
RYAM Yearly Profit, Operating, Gross MarginsRYAM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. RYAM Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so RYAM is destroying value.
  • The number of shares outstanding for RYAM has been increased compared to 1 year ago.
  • Compared to 5 years ago, RYAM has more shares outstanding
  • RYAM has a worse debt/assets ratio than last year.
RYAM Yearly Shares OutstandingRYAM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
RYAM Yearly Total Debt VS Total AssetsRYAM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • Based on the Altman-Z score of 1.19, we must say that RYAM is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of RYAM (1.19) is worse than 76.83% of its industry peers.
  • RYAM has a Debt/Equity ratio of 2.39. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 2.39, RYAM is not doing good in the industry: 86.59% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.39
Debt/FCF N/A
Altman-Z 1.19
ROIC/WACC0.04
WACC12.95%
RYAM Yearly LT Debt VS Equity VS FCFRYAM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • RYAM has a Current Ratio of 1.58. This is a normal value and indicates that RYAM is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.58, RYAM is doing worse than 65.85% of the companies in the same industry.
  • RYAM has a Quick Ratio of 1.58. This is a bad value and indicates that RYAM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • RYAM has a Quick ratio of 0.92. This is in the lower half of the industry: RYAM underperforms 68.29% of its industry peers.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 0.92
RYAM Yearly Current Assets VS Current LiabilitesRYAM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. RYAM Growth Analysis

3.1 Past

  • The earnings per share for RYAM have decreased strongly by -12560.00% in the last year.
  • RYAM shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.05%.
  • The Revenue has been growing slightly by 1.76% on average over the past years.
EPS 1Y (TTM)-12560%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
Revenue 1Y (TTM)-10.05%
Revenue growth 3Y-5.13%
Revenue growth 5Y1.76%
Sales Q2Q%-1.18%

3.2 Future

  • RYAM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 48.72% yearly.
  • Based on estimates for the next years, RYAM will show a small growth in Revenue. The Revenue will grow by 4.53% on average per year.
EPS Next Y88.83%
EPS Next 2Y48.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.97%
Revenue Next 2Y4.53%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
RYAM Yearly Revenue VS EstimatesRYAM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
RYAM Yearly EPS VS EstimatesRYAM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4 -6

More info and screens

Find the best growth stocksShow best growing peers

1

4. RYAM Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for RYAM. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RYAM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RYAM Price Earnings VS Forward Price EarningsRYAM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of RYAM indicates a somewhat cheap valuation: RYAM is cheaper than 70.73% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.39
RYAM Per share dataRYAM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

  • RYAM's earnings are expected to grow with 48.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y48.72%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. RYAM Dividend Analysis

5.1 Amount

  • RYAM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

RYAM Fundamentals: All Metrics, Ratios and Statistics

RAYONIER ADVANCED MATERIALS

NYSE:RYAM (4/24/2026, 8:07:16 PM)

After market: 9.62 0 (0%)

9.62

-0.13 (-1.33%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)03-03
Earnings (Next)05-05
Inst Owners67.28%
Inst Owner Change0.03%
Ins Owners3.98%
Ins Owner Change0.72%
Market Cap648.29M
Revenue(TTM)1.47B
Net Income(TTM)-420.67M
Analysts82.86
Price Target14.79 (53.74%)
Short Float %4.7%
Short Ratio2.61
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-289.67%
Min EPS beat(2)-311.68%
Max EPS beat(2)-267.65%
EPS beat(4)0
Avg EPS beat(4)-894.62%
Min EPS beat(4)-2198.35%
Max EPS beat(4)-267.65%
EPS beat(8)3
Avg EPS beat(8)-401.34%
EPS beat(12)3
Avg EPS beat(12)-485.93%
EPS beat(16)6
Avg EPS beat(16)-345.89%
Revenue beat(2)1
Avg Revenue beat(2)1.87%
Min Revenue beat(2)-7.39%
Max Revenue beat(2)11.12%
Revenue beat(4)1
Avg Revenue beat(4)-5.21%
Min Revenue beat(4)-13.53%
Max Revenue beat(4)11.12%
Revenue beat(8)2
Avg Revenue beat(8)-4.48%
Revenue beat(12)4
Avg Revenue beat(12)-4.22%
Revenue beat(16)7
Avg Revenue beat(16)-2.13%
PT rev (1m)61.11%
PT rev (3m)61.11%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1466.68%
EPS NY rev (1m)-298.09%
EPS NY rev (3m)-262.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-14.91%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.63%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.44
P/FCF N/A
P/OCF 27.11
P/B 2.05
P/tB 2.07
EV/EBITDA 9.39
EPS(TTM)-6.33
EYN/A
EPS(NY)-0.71
Fwd EYN/A
FCF(TTM)-1.36
FCFYN/A
OCF(TTM)0.35
OCFY3.69%
SpS21.76
BVpS4.7
TBVpS4.64
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -23.92%
ROE -132.89%
ROCE 0.72%
ROIC 0.57%
ROICexc 0.6%
ROICexgc 0.6%
OM 0.68%
PM (TTM) N/A
GM 8.1%
FCFM N/A
ROA(3y)-10.14%
ROA(5y)-5.67%
ROE(3y)-50.65%
ROE(5y)-29.12%
ROIC(3y)1.56%
ROIC(5y)N/A
ROICexc(3y)1.67%
ROICexc(5y)N/A
ROICexgc(3y)1.68%
ROICexgc(5y)N/A
ROCE(3y)1.97%
ROCE(5y)N/A
ROICexgc growth 3Y-22.11%
ROICexgc growth 5YN/A
ROICexc growth 3Y-21.84%
ROICexc growth 5YN/A
OM growth 3Y-26.22%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.16%
GM growth 5Y11.42%
F-Score5
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 2.39
Debt/FCF N/A
Debt/EBITDA 5.27
Cap/Depr 86.3%
Cap/Sales 7.88%
Interest Coverage 0.1
Cash Conversion 16.61%
Profit Quality N/A
Current Ratio 1.58
Quick Ratio 0.92
Altman-Z 1.19
F-Score5
WACC12.95%
ROIC/WACC0.04
Cap/Depr(3y)85.4%
Cap/Depr(5y)85.54%
Cap/Sales(3y)7.42%
Cap/Sales(5y)7.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12560%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
EPS Next Y88.83%
EPS Next 2Y48.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-10.05%
Revenue growth 3Y-5.13%
Revenue growth 5Y1.76%
Sales Q2Q%-1.18%
Revenue Next Year0.97%
Revenue Next 2Y4.53%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-87.55%
EBIT growth 3Y-30.01%
EBIT growth 5YN/A
EBIT Next Year1851.87%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-195.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-88.26%
OCF growth 3Y-29.69%
OCF growth 5Y-28.11%

RAYONIER ADVANCED MATERIALS / RYAM Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for RAYONIER ADVANCED MATERIALS?

ChartMill assigns a fundamental rating of 1 / 10 to RYAM.


What is the valuation status of RAYONIER ADVANCED MATERIALS (RYAM) stock?

ChartMill assigns a valuation rating of 1 / 10 to RAYONIER ADVANCED MATERIALS (RYAM). This can be considered as Overvalued.


Can you provide the profitability details for RAYONIER ADVANCED MATERIALS?

RAYONIER ADVANCED MATERIALS (RYAM) has a profitability rating of 2 / 10.


Can you provide the financial health for RYAM stock?

The financial health rating of RAYONIER ADVANCED MATERIALS (RYAM) is 0 / 10.


Can you provide the expected EPS growth for RYAM stock?

The Earnings per Share (EPS) of RAYONIER ADVANCED MATERIALS (RYAM) is expected to grow by 88.83% in the next year.